Highlights

  • The company's main site is a coastal Lease of about 3.4 hectares at Laikang Village in Takalar Regency.
  • Ocean Sciences has yet to confirm partners for the work and gives no assurance of technical or commercial success.
  • Directors and related parties are taking AUD 148,000, subject to approval at a December general meeting.
  • The company changed its name and consolidated its shares one-for-ten during the September quarter, so older price comparisons need adjusting.

Ocean Sciences (ASX:OSS), the Indonesian seaweed trader formerly known as BPH Global, has raised fresh Capital after its cash balance fell close to zero. In early November the company secured commitments for a AUD 700,000 placement. At the end of September its Appendix 4C showed just AUD 72,000 in cash and an estimated 0.4 quarters of funding. The raising gives it room to pursue export growth and a planned seaweed research centre in South Sulawesi.

What the company does

Ocean Sciences trades raw seaweed in Indonesia through its Subsidiary PT BPH Global Indonesia. Cumulative sales since May 2025 total about AUD 3.87 million. In the quarter it began exporting raw seaweed directly to China following approval from China's customs authority, with a first shipment delivered on 22 July 2026. Delivery was subject to customs clearance, and no price was disclosed. Spinosum is the raw material for iota-carrageenan and extends the company beyond Cottonii, which serves the kappa-carrageenan market.

The lease has been extended to April 2031, and the company is planning a Seaweed Innovation and Application Centre there. A development plan was released on 1 October.

Research projects

In October the company announced two early-stage research initiatives. It provided an update on seaweed-based bio-fertiliser research and commercialisation. On 28 October it approved an initial AUD 100,000 for a programme of at least 12 months testing whether alginate from Sargassum seaweed can recover gold and silver from retired data centre hardware. It also signed a non-binding memorandum of understanding with the Australia-Indonesia Centre on 20 October.

Cash and the placement

The Appendix 4C for the quarter to 30 September 2026 shows customer receipts of about AUD 960,000, a net operating outflow of about AUD 178,000 and cash falling from AUD 253,000 to AUD 72,000. A USD 375,000 trade finance Facility from Equentia Natural Resources, at 15% interest and secured over seaweed stock, is fully drawn and has been extended to August 2027. Related-party payments were about AUD 110,000.

The non-related shares were due for allotment on 11 November, and the company lodged a Quotation application and cleansing notice that day. A loyalty Options offer to existing shareholders is planned within about three months.

Risks

The company is small and trades on thin margins in a Commodity market, with exposure to Chinese customs, Demand and pricing. Research programmes into fertilisers and metal recovery are at an early stage.

Share Trading on 16 November

The price was slightly above the 1.1-cent Placement price.

What to watch

Upcoming items include the December general meeting to approve director shares and options, the loyalty options offer, progress on Spinosum and Cottonii exports to China, and construction steps at the Takalar centre.